Bookimed does not add extra charges for Hematology Oncology treatment prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your treatment upon your arrival to the country.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hematology Oncology treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hematology Oncology treatment journey.
Quiron Barcelona Hospital is a top clinic in Spain, known for its advanced oncology care through the Baselga Institute of Oncology, which collaborates with leading American centers. With 23 operating rooms and cutting-edge technology like PET-CT and MRI, it offers precise and effective treatments, including robotized surgeries and assisted reproduction.
The hospital provides personalized care for international patients, with 165 wards, suites, and royal apartments. Services include tailored treatment plans, WiFi, airport transfers, and nearby hotel accommodations, making it a preferred choice for high-quality medical care.
Clinic HM Nou Delfos is a comprehensive medical-surgical center in Barcelona, which is a part of the largest network in Spain – HM Hospitals. HM Delfos specializes in surgery, oncology, orthopedics, cardiology, gynecology, urology, neurology including diagnosis and treatment of epilepsy. The clinic is equipped with the very latest devices for diagnostics and treatment: EOS for high-precision images of the musculoskeletal system, CT and MRI, two units for radiotherapy of tumors without surgery.
The clinic has also the agreement with Institut Guttmann, neurorehabilitation hospital with JCI, AQU Catalunya, and ISO quality certificates for rehabilitation.
Children's Hematologist. Specialist in bone marrow transplantation
Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.
Written by Anna Leonova